Luca Marini

Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study

Valentina Guarneri, Antonio Frassoldati, Alberto Bottini et al. · Journal of Clinical Oncology · 2012 · 368 citations · Full text

Medicine, Oncology, Pharmacology +16

Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial

Luigi Dogliotti, Giacomo Cartenì, Salvatore Siena et al. · European Urology · 2007 · 329 citations

Medicine, Oncology, Pharmacology +10

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy

Cora N. Sternberg, Fabio Calabr�, Giorgio Pizzocaro et al. · Cancer · 2001 · 208 citations

Medicine, Oncology, Pharmacology +15

Cellular and Pharmacogenetics Foundation of Synergistic Interaction of Pemetrexed and Gemcitabine in Human Non–Small-Cell Lung Cancer Cells

Elisa Giovannetti, Valentina Mey, Sara Nannizzi et al. · Molecular Pharmacology · 2005 · 178 citations · Full text

Medicine, Oncology, Pharmacology +17

A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer

Giuseppe Roberto D’Agostino, J. Del Campo, Begoña Mellado et al. · International Journal of Gynecological Cancer · 2006 · 83 citations

Medicine, Oncology, Pharmacology +16